IBDEI1QD ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,27659,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27659,1,3,0)
;;=3^Neuroleptic-Induced Parkinsonism
;;^UTILITY(U,$J,358.3,27659,1,4,0)
;;=4^G21.11
;;^UTILITY(U,$J,358.3,27659,2)
;;=^5003772
;;^UTILITY(U,$J,358.3,27660,0)
;;=G24.01^^113^1347^15
;;^UTILITY(U,$J,358.3,27660,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27660,1,3,0)
;;=3^Tardive Dyskinesia
;;^UTILITY(U,$J,358.3,27660,1,4,0)
;;=4^G24.01
;;^UTILITY(U,$J,358.3,27660,2)
;;=^5003784
;;^UTILITY(U,$J,358.3,27661,0)
;;=G24.09^^113^1347^16
;;^UTILITY(U,$J,358.3,27661,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27661,1,3,0)
;;=3^Tardive Dystonia
;;^UTILITY(U,$J,358.3,27661,1,4,0)
;;=4^G24.09
;;^UTILITY(U,$J,358.3,27661,2)
;;=^5003786
;;^UTILITY(U,$J,358.3,27662,0)
;;=G25.1^^113^1347^11
;;^UTILITY(U,$J,358.3,27662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27662,1,3,0)
;;=3^Medication-Induced Postural Tremor
;;^UTILITY(U,$J,358.3,27662,1,4,0)
;;=4^G25.1
;;^UTILITY(U,$J,358.3,27662,2)
;;=^5003792
;;^UTILITY(U,$J,358.3,27663,0)
;;=G25.71^^113^1347^14
;;^UTILITY(U,$J,358.3,27663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27663,1,3,0)
;;=3^Tardive Akathisia
;;^UTILITY(U,$J,358.3,27663,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,27663,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,27664,0)
;;=G25.79^^113^1347^9
;;^UTILITY(U,$J,358.3,27664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27664,1,3,0)
;;=3^Medication-Induced Movement Disorder,Other
;;^UTILITY(U,$J,358.3,27664,1,4,0)
;;=4^G25.79
;;^UTILITY(U,$J,358.3,27664,2)
;;=^5003800
;;^UTILITY(U,$J,358.3,27665,0)
;;=T43.205A^^113^1347^4
;;^UTILITY(U,$J,358.3,27665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27665,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
;;^UTILITY(U,$J,358.3,27665,1,4,0)
;;=4^T43.205A
;;^UTILITY(U,$J,358.3,27665,2)
;;=^5050540
;;^UTILITY(U,$J,358.3,27666,0)
;;=T43.205D^^113^1347^5
;;^UTILITY(U,$J,358.3,27666,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27666,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
;;^UTILITY(U,$J,358.3,27666,1,4,0)
;;=4^T43.205D
;;^UTILITY(U,$J,358.3,27666,2)
;;=^5050541
;;^UTILITY(U,$J,358.3,27667,0)
;;=T43.205S^^113^1347^6
;;^UTILITY(U,$J,358.3,27667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27667,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Sequela
;;^UTILITY(U,$J,358.3,27667,1,4,0)
;;=4^T43.205S
;;^UTILITY(U,$J,358.3,27667,2)
;;=^5050542
;;^UTILITY(U,$J,358.3,27668,0)
;;=G25.71^^113^1347^7
;;^UTILITY(U,$J,358.3,27668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27668,1,3,0)
;;=3^Medication-Induced Acute Akathisia
;;^UTILITY(U,$J,358.3,27668,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,27668,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,27669,0)
;;=G24.02^^113^1347^8
;;^UTILITY(U,$J,358.3,27669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27669,1,3,0)
;;=3^Medication-Induced Acute Dystonia
;;^UTILITY(U,$J,358.3,27669,1,4,0)
;;=4^G24.02
;;^UTILITY(U,$J,358.3,27669,2)
;;=^5003785
;;^UTILITY(U,$J,358.3,27670,0)
;;=G21.0^^113^1347^12
;;^UTILITY(U,$J,358.3,27670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,27670,1,3,0)
;;=3^Neuroleptic Malignant Syndrome
;;^UTILITY(U,$J,358.3,27670,1,4,0)
;;=4^G21.0
;;^UTILITY(U,$J,358.3,27670,2)
;;=^5003771
;;^UTILITY(U,$J,358.3,27671,0)
;;=T50.905A^^113^1347^1
;;^UTILITY(U,$J,358.3,27671,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1QD 3780 printed Nov 22, 2024@17:23:56 Page 2
IBDEI1QD ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,27659,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,27659,1,3,0)
+4 ;;=3^Neuroleptic-Induced Parkinsonism
+5 ;;^UTILITY(U,$J,358.3,27659,1,4,0)
+6 ;;=4^G21.11
+7 ;;^UTILITY(U,$J,358.3,27659,2)
+8 ;;=^5003772
+9 ;;^UTILITY(U,$J,358.3,27660,0)
+10 ;;=G24.01^^113^1347^15
+11 ;;^UTILITY(U,$J,358.3,27660,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,27660,1,3,0)
+14 ;;=3^Tardive Dyskinesia
+15 ;;^UTILITY(U,$J,358.3,27660,1,4,0)
+16 ;;=4^G24.01
+17 ;;^UTILITY(U,$J,358.3,27660,2)
+18 ;;=^5003784
+19 ;;^UTILITY(U,$J,358.3,27661,0)
+20 ;;=G24.09^^113^1347^16
+21 ;;^UTILITY(U,$J,358.3,27661,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,27661,1,3,0)
+24 ;;=3^Tardive Dystonia
+25 ;;^UTILITY(U,$J,358.3,27661,1,4,0)
+26 ;;=4^G24.09
+27 ;;^UTILITY(U,$J,358.3,27661,2)
+28 ;;=^5003786
+29 ;;^UTILITY(U,$J,358.3,27662,0)
+30 ;;=G25.1^^113^1347^11
+31 ;;^UTILITY(U,$J,358.3,27662,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,27662,1,3,0)
+34 ;;=3^Medication-Induced Postural Tremor
+35 ;;^UTILITY(U,$J,358.3,27662,1,4,0)
+36 ;;=4^G25.1
+37 ;;^UTILITY(U,$J,358.3,27662,2)
+38 ;;=^5003792
+39 ;;^UTILITY(U,$J,358.3,27663,0)
+40 ;;=G25.71^^113^1347^14
+41 ;;^UTILITY(U,$J,358.3,27663,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,27663,1,3,0)
+44 ;;=3^Tardive Akathisia
+45 ;;^UTILITY(U,$J,358.3,27663,1,4,0)
+46 ;;=4^G25.71
+47 ;;^UTILITY(U,$J,358.3,27663,2)
+48 ;;=^5003799
+49 ;;^UTILITY(U,$J,358.3,27664,0)
+50 ;;=G25.79^^113^1347^9
+51 ;;^UTILITY(U,$J,358.3,27664,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,27664,1,3,0)
+54 ;;=3^Medication-Induced Movement Disorder,Other
+55 ;;^UTILITY(U,$J,358.3,27664,1,4,0)
+56 ;;=4^G25.79
+57 ;;^UTILITY(U,$J,358.3,27664,2)
+58 ;;=^5003800
+59 ;;^UTILITY(U,$J,358.3,27665,0)
+60 ;;=T43.205A^^113^1347^4
+61 ;;^UTILITY(U,$J,358.3,27665,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,27665,1,3,0)
+64 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
+65 ;;^UTILITY(U,$J,358.3,27665,1,4,0)
+66 ;;=4^T43.205A
+67 ;;^UTILITY(U,$J,358.3,27665,2)
+68 ;;=^5050540
+69 ;;^UTILITY(U,$J,358.3,27666,0)
+70 ;;=T43.205D^^113^1347^5
+71 ;;^UTILITY(U,$J,358.3,27666,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,27666,1,3,0)
+74 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
+75 ;;^UTILITY(U,$J,358.3,27666,1,4,0)
+76 ;;=4^T43.205D
+77 ;;^UTILITY(U,$J,358.3,27666,2)
+78 ;;=^5050541
+79 ;;^UTILITY(U,$J,358.3,27667,0)
+80 ;;=T43.205S^^113^1347^6
+81 ;;^UTILITY(U,$J,358.3,27667,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,27667,1,3,0)
+84 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
+85 ;;^UTILITY(U,$J,358.3,27667,1,4,0)
+86 ;;=4^T43.205S
+87 ;;^UTILITY(U,$J,358.3,27667,2)
+88 ;;=^5050542
+89 ;;^UTILITY(U,$J,358.3,27668,0)
+90 ;;=G25.71^^113^1347^7
+91 ;;^UTILITY(U,$J,358.3,27668,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,27668,1,3,0)
+94 ;;=3^Medication-Induced Acute Akathisia
+95 ;;^UTILITY(U,$J,358.3,27668,1,4,0)
+96 ;;=4^G25.71
+97 ;;^UTILITY(U,$J,358.3,27668,2)
+98 ;;=^5003799
+99 ;;^UTILITY(U,$J,358.3,27669,0)
+100 ;;=G24.02^^113^1347^8
+101 ;;^UTILITY(U,$J,358.3,27669,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,27669,1,3,0)
+104 ;;=3^Medication-Induced Acute Dystonia
+105 ;;^UTILITY(U,$J,358.3,27669,1,4,0)
+106 ;;=4^G24.02
+107 ;;^UTILITY(U,$J,358.3,27669,2)
+108 ;;=^5003785
+109 ;;^UTILITY(U,$J,358.3,27670,0)
+110 ;;=G21.0^^113^1347^12
+111 ;;^UTILITY(U,$J,358.3,27670,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,27670,1,3,0)
+114 ;;=3^Neuroleptic Malignant Syndrome
+115 ;;^UTILITY(U,$J,358.3,27670,1,4,0)
+116 ;;=4^G21.0
+117 ;;^UTILITY(U,$J,358.3,27670,2)
+118 ;;=^5003771
+119 ;;^UTILITY(U,$J,358.3,27671,0)
+120 ;;=T50.905A^^113^1347^1
+121 ;;^UTILITY(U,$J,358.3,27671,1,0)
+122 ;;=^358.31IA^4^2
